The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

BACKGROUND: Iron deficiency anemia (IDA) is a common manifestation of chronic kidney disease (CKD), affecting most patients on hemodialysis and imposing a substantial clinical burden. Treatment with iron supplementation increases hemoglobin levels and can reduce the severity of anemia in patients wi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Nephrol
Autori principali: Macdougall, Iain C., Dahl, Naomi V., Bernard, Kristine, Li, Zhu, Batyky, Alka, Strauss, William E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379516/
https://ncbi.nlm.nih.gov/pubmed/28372549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0523-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi